We assembled an ancestrally diverse collection of genome-wide association studies (GWAS)
of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non…

We expanded GWAS discovery for type 2 diabetes (T2D) by combining data from 898,130
European-descent individuals (9% cases), after imputation to high-density reference panels. …

We aggregated coding variant data for 81,412 type 2 diabetes cases and 370,832 controls
of diverse ancestry, identifying 40 coding variant association signals (P < 2.2 × 10 −7 ); of …

Gestational diabetes mellitus (GDM) is associated with increased risk of pregnancy
complications and adverse perinatal outcomes. GDM often reoccurs and is associated with …

The presentation and underlying pathophysiology of type 2 diabetes (T2D) is complex and
heterogeneous. Recent studies attempted to stratify T2D into distinct subgroups using data-…

The concentrations of high- and low-density-lipoprotein cholesterol and triglycerides are
influenced by smoking, but it is unknown whether genetic associations with lipids may be …

Chronic kidney disease (CKD) is responsible for a public health burden with multi-systemic
complications. Through trans-ancestry meta-analysis of genome-wide association studies of …

We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing
2,973 individuals across three molecular classes, metabolites, lipids and proteins. …

The hepatokine follistatin is elevated in patients with type 2 diabetes (T2D) and promotes
hyperglycemia in mice. Here we explore the relationship of plasma follistatin levels with …

Heavy alcohol consumption is an established risk factor for hypertension; the mechanism by
which alcohol consumption impact blood pressure (BP) regulation remains unknown. We …